Download presentation
Presentation is loading. Please wait.
Published byEzra Hopkins Modified over 9 years ago
1
Decline in reported GC morbidity in NYC Preeti Pathela ppathela@health.nyc.gov
2
Where do we stand? NYC US Gonorrhea Cases per 100,000 pop.
3
Gonorrhea Rates: United States, 1970-2004 and the Healthy People 2010 target -74% -12%
4
Gonorrhea Rates by Sex: United States, 1981-2004 and the Healthy People 2010 target
5
Gonorrhea Rates by Sex New York City, 1995-2005 Data based on cases reported to the NYC DOHMH
6
Gonorrhea Rates by Provider Type: United States, 1984-2004
7
Case rate (per 100,000 population) of Neisseria gonorrhea reported to the New York City DOHMH, with percent reported from Bureau of STD clinics, 2000-2005, by sex Data based on cases reported to the NYC DOHMH
8
HIV Counseling & Testing STD Clinic Drug Treatment Family Planning Prenatal Other Clinic Private Physician Hospital Correctional Facility Laboratory Other Unknown Provider types in NYC BSTDC Surveillance Database
9
N=5507N=5286 N=6720 N=6330
10
NYC DOHMH Reported female gonorrhea cases, by provider type 2002 - 2005 N=5048N=5544 N=6691N=6646
11
10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+ Age (years) Males N=5286 Females N=5544 Gonorrhea reported to the NYC DOHMH. Case rates (per 100,000 population) by age and sex*, full year 2004 * Excludes persons for whom age or sex information is missing. Case rate /100,000 population
12
Male GC positivity by age BSTDC clinics, 2003-2005
13
Female GC positivity by age BSTDC clinics, 2003-2005
14
A true decline in GC Changes in screening practices Use of diagnostic tests with different sensitivities Changes in reporting practices What is leading to the apparent decline in GC cases?
15
If decreases are true decreases… How would this impact targeting of GC screening? Could this impact manufacturers of tests (provision of Ct-only tests) for low GC prevalence areas?
16
Thanks!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.